What is ALT (Alanine Aminotransferase)?

ALT is a liver enzyme that helps assess liver health, with normal levels typically under 40 U/L for men and 35 U/L for women. Elevated ALT can indicate liver damage from various causes including fatty liver disease, hepatitis, medications, or alcohol use.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ALT: Your Liver's Health Indicator

Alanine aminotransferase (ALT) is an enzyme found primarily in liver cells that plays a crucial role in amino acid metabolism. When liver cells are damaged or inflamed, ALT leaks into the bloodstream, making it one of the most sensitive markers for detecting liver injury. This enzyme helps convert the amino acid alanine into pyruvate, an important molecule in cellular energy production.

ALT testing has become a cornerstone of liver function assessment, often included in comprehensive metabolic panels and routine health screenings. Unlike some biomarkers that fluctuate throughout the day, ALT levels remain relatively stable, making it a reliable indicator of liver health when measured properly.

Normal ALT Ranges and What They Mean

Normal ALT levels vary slightly between laboratories and populations, but generally fall within these ranges:

ALT Level Categories and Clinical Significance

ALT levels should be interpreted alongside other liver function tests and clinical symptoms for accurate diagnosis.
ALT LevelCategoryPotential CausesRecommended Action
Normal<40 U/L (men), <35 U/L (women)NormalHealthy liver functionContinue healthy lifestyle, annual monitoring
Mild Elevation1-3x upper normal limitMild elevationNAFLD, medications, mild inflammationLifestyle modifications, retest in 3-6 months
Moderate Elevation3-10x upper normal limitModerate elevationActive hepatitis, alcohol use, autoimmune conditionsFurther testing, identify underlying cause
Severe Elevation>10x upper normal limitSevere elevationAcute liver injury, viral hepatitis, drug toxicityImmediate medical evaluation required

ALT levels should be interpreted alongside other liver function tests and clinical symptoms for accurate diagnosis.

  • Men: 10-40 U/L (units per liter)
  • Women: 7-35 U/L
  • Children: May have slightly higher normal ranges

However, recent research suggests that optimal ALT levels may be lower than traditional reference ranges. Some experts recommend aiming for ALT levels below 30 U/L for men and 25 U/L for women, as even high-normal levels may indicate early liver stress. Understanding your baseline ALT and tracking changes over time provides valuable insight into your liver health.

Factors Affecting ALT Levels

Several factors can influence ALT levels beyond liver health. Body weight, particularly obesity, is strongly associated with elevated ALT due to increased risk of fatty liver disease. Exercise can temporarily raise ALT levels, especially after intense workouts that cause muscle damage. Certain medications, including statins, antibiotics, and over-the-counter pain relievers like acetaminophen, can also affect ALT readings.

Common Causes of Elevated ALT

When ALT levels rise above normal ranges, it typically indicates some form of liver stress or damage. The most common causes include:

Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD has become the leading cause of elevated ALT in developed countries, affecting up to 25% of adults. This condition occurs when excess fat accumulates in liver cells, often related to obesity, insulin resistance, and metabolic syndrome. ALT levels in NAFLD typically range from 1.5 to 3 times the upper normal limit.

Viral Hepatitis

Hepatitis B and C infections can cause significant ALT elevations, sometimes reaching 10-20 times normal levels during acute infection. Chronic hepatitis may show more modest elevations, making regular monitoring essential for tracking disease progression and treatment response.

While alcohol typically affects another liver enzyme (AST) more than ALT, chronic alcohol consumption can still elevate ALT levels. The pattern of enzyme elevation, particularly the AST:ALT ratio, helps healthcare providers distinguish between alcoholic and non-alcoholic liver disease.

Other causes of elevated ALT include autoimmune hepatitis, hemochromatosis (iron overload), Wilson's disease (copper accumulation), celiac disease, and certain herbal supplements or toxins. Regular monitoring of ALT alongside other liver markers helps identify these conditions early when treatment is most effective.

ALT in Relation to Other Liver Tests

ALT is rarely evaluated in isolation. Healthcare providers typically order it alongside other liver function tests to get a comprehensive picture of liver health:

  • AST (Aspartate Aminotransferase): Another liver enzyme that, when compared with ALT, helps determine the type and severity of liver damage
  • ALP (Alkaline Phosphatase): Elevated levels may indicate bile duct problems or bone disease
  • Bilirubin: Measures the liver's ability to process waste products
  • Albumin and Total Protein: Assess the liver's synthetic function
  • GGT (Gamma-Glutamyl Transferase): Particularly sensitive to alcohol use and bile duct problems

The AST:ALT ratio provides particularly valuable diagnostic information. A ratio greater than 2:1 often suggests alcoholic liver disease, while a ratio less than 1:1 is more common in NAFLD and viral hepatitis. This pattern recognition helps guide further testing and treatment decisions.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

When to Test Your ALT Levels

ALT testing is recommended in several situations:

  1. Annual health screenings for adults, especially those with risk factors for liver disease
  2. Before starting medications known to affect the liver
  3. When experiencing symptoms like fatigue, abdominal pain, or jaundice
  4. To monitor known liver conditions or treatment effectiveness
  5. As part of metabolic health assessment in people with diabetes, obesity, or metabolic syndrome

For individuals with elevated ALT, follow-up testing frequency depends on the underlying cause and severity. Mild elevations may require retesting in 3-6 months, while more significant abnormalities warrant closer monitoring and additional investigation.

Lifestyle Factors That Impact ALT

Your daily habits significantly influence ALT levels and overall liver health. Diet plays a crucial role, with high intake of processed foods, added sugars, and saturated fats contributing to fatty liver disease and elevated ALT. Conversely, a Mediterranean-style diet rich in vegetables, whole grains, and healthy fats has been shown to reduce ALT levels and improve liver health.

Regular physical activity helps maintain healthy ALT levels by reducing liver fat, improving insulin sensitivity, and promoting healthy weight management. Studies show that both aerobic exercise and resistance training can lower ALT levels, with combination programs showing the greatest benefits. Even modest weight loss of 5-10% can significantly improve ALT levels in people with NAFLD.

Medications and Supplements

Many common medications can affect ALT levels, including statins for cholesterol management, certain antibiotics, and nonsteroidal anti-inflammatory drugs (NSAIDs). While these medications are often necessary and beneficial, regular ALT monitoring helps ensure liver safety. Some supplements, particularly high-dose vitamin A, kava, and certain weight-loss products, have been associated with liver injury and ALT elevation.

Interpreting Your ALT Results

Understanding your ALT results requires context. A single elevated reading doesn't necessarily indicate serious liver disease, as temporary factors like recent exercise, medication use, or even a recent illness can cause transient elevations. However, persistently elevated ALT warrants further investigation.

The degree of ALT elevation provides clues about potential causes. Mild elevations (less than 3 times normal) are often seen in NAFLD, medication effects, or chronic viral hepatitis. Moderate elevations (3-10 times normal) may indicate more active liver inflammation, while severe elevations (greater than 10 times normal) suggest acute liver injury requiring immediate medical attention.

Taking Action on Abnormal ALT Levels

If your ALT levels are elevated, several steps can help improve liver health:

  1. Work with your healthcare provider to identify and address underlying causes
  2. Achieve and maintain a healthy weight through balanced nutrition and regular exercise
  3. Limit alcohol consumption or abstain completely if advised
  4. Review all medications and supplements with your provider
  5. Manage underlying conditions like diabetes and high cholesterol
  6. Consider additional testing such as liver imaging or specialized blood tests

For many people with mildly elevated ALT due to fatty liver disease, lifestyle modifications can normalize levels within 3-6 months. This includes adopting a Mediterranean-style diet, increasing physical activity to at least 150 minutes per week, and achieving modest weight loss. Regular monitoring helps track progress and adjust interventions as needed.

The Future of Liver Health Monitoring

As our understanding of liver health evolves, ALT remains a valuable but not exclusive marker. Emerging biomarkers and non-invasive tests like FibroScan provide additional insights into liver health beyond what ALT alone can reveal. Combining ALT with other metabolic markers, imaging studies, and clinical assessment offers the most comprehensive approach to liver health monitoring.

Regular ALT testing, especially when combined with a comprehensive metabolic panel, empowers individuals to take proactive steps in maintaining liver health. By understanding what ALT measures, recognizing factors that influence it, and taking appropriate action when levels are abnormal, you can protect one of your body's most vital organs and support overall metabolic health.

References

  1. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.[Link][PubMed][DOI]
  2. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.[PubMed][DOI]
  3. Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology. 2012;55(2):447-454.[PubMed][DOI]
  4. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;149(2):367-378.[PubMed][DOI]
  5. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599.[PubMed][DOI]
  6. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALT at home?

You can test your ALT at home with SiPhox Health's Heart & Metabolic Program, which includes ALT testing along with other essential liver enzymes like AST, bilirubin, and albumin. The program provides CLIA-certified lab results from a simple at-home blood draw.

What is the normal range for ALT?

Normal ALT ranges are typically 10-40 U/L for men and 7-35 U/L for women, though optimal levels may be lower (under 30 U/L for men and 25 U/L for women). These ranges can vary slightly between laboratories.

How often should I test my ALT levels?

For general health monitoring, annual testing is recommended. If you have elevated ALT or risk factors for liver disease, testing every 3-6 months may be appropriate. Those with known liver conditions may need more frequent monitoring as directed by their healthcare provider.

Can exercise affect my ALT test results?

Yes, intense exercise can temporarily elevate ALT levels due to muscle damage, as ALT is also present in muscle tissue. It's best to avoid strenuous exercise for 24-48 hours before ALT testing for the most accurate results.

What should I do if my ALT is elevated?

First, don't panic - a single elevated reading may be temporary. Work with your healthcare provider to identify potential causes, review medications and supplements, and consider lifestyle modifications like improving diet, increasing exercise, and achieving a healthy weight. Follow-up testing is usually recommended to confirm persistent elevation.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details